BeiGene, Ltd. (BGNE): Price and Financial Metrics
BeiGene, Ltd. (BGNE)
Today's Latest Price: $222.88 USD
Updated Dec 4 4:00pm
Add BGNE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BGNE Stock Summary
- BeiGene Ltd's market capitalization of $20,676,200,283 is ahead of 90.2% of US-listed equities.
- BGNE's price/sales ratio is 77.83; that's higher than the P/S ratio of 96.54% of US stocks.
- Revenue growth over the past 12 months for BeiGene Ltd comes in at -38.22%, a number that bests just 8.46% of the US stocks we're tracking.
- Stocks that are quantitatively similar to BGNE, based on their financial statements, market capitalization, and price volatility, are SRPT, XLRN, MXIM, INCY, and FOLD.
- Visit BGNE's SEC page to see the company's official filings. To visit the company's web site, go to www.beigene.com.
BGNE Stock Price Chart Interactive Chart >
BGNE Price/Volume Stats
| Current price | $222.88 | 52-week high | $322.98 |
| Prev. close | $221.31 | 52-week low | $118.55 |
| Day low | $220.64 | Volume | 639,400 |
| Day high | $228.64 | Avg. volume | 315,684 |
| 50-day MA | $286.53 | Dividend yield | N/A |
| 200-day MA | $212.09 | Market Cap | 20.24B |
BeiGene, Ltd. (BGNE) Company Bio
BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.
Loading social stream, please wait...